Solvay Pharmaceuticals, Inc. Awards 30 Scholarships to Students with Cystic Fibrosis
MARIETTA, Ga., Oct. 25, 2005 – Solvay Pharmaceuticals, Inc. has selected 30 students with cystic fibrosis (CF) to receive a 2005-2006 CREON® Family Scholarship. These winners are being recognized for their academic excellence as well as their courage in battling CF, an incurable genetic disease.
Each student will receive $2,000 per year for up to two years of study and a year’s supply of CREON® MINIMICROSPHERES® (pancrelipase delayed-release capsules, USP) and SourceCF® SOFTGELS Multivitamins. At the end of each two-year award period, recipients are eligible to apply for additional scholarship funding.
Now in its 13th year, the CREON® Family Scholarship program is funded by Solvay Pharmaceuticals. Since the program’s inception, the company has awarded nearly 300 scholarships totaling more than $1.6 million.
Scholarships are awarded to students based on academic achievement, financial need, leadership qualities and the ability to serve as a role model to others with CF. All U.S. citizens with CF who are high school seniors, college or vocational school students who began or continued higher education in the fall of 2005 are eligible to apply. Applications are available at CF treatment centers nationwide each year from March through June.
The following students were awarded scholarships for the 2005-2006 academic year:
Stacy Baker, Winamac, Ind.
Julie E. Moritz, San Diego
Lawrence C. Banko, Waterford, Mich.
Shannon O’Donnell, Toms River, N.J.
Zackary R. Cashatt, Randleman, N.C.
Caprice M. Padilla, El Paso, Texas
Keith Connolly, Cincinnati
Toni D. Pauline, Fort Atkinson, Wisc.
Kyle Connolly, Cincinnati
Samantha Pelican, Denver
Katherine E. DeVoe, Decatur, Ala.
Kaly Prather, Lee’s Summit, Mo.
Alanna Donovan-Smith, Houston
Alexander B. Prator, Paradise, Calif.
Haley Dowdell, Wakefield, R.I.
Megan G. Scott, West Jordan, Utah
Tyler J. Foote, Goshen, Ky.
Nicholas A. Scribani, Fairport, N.Y.
Charles Frazier, Chapel Hill, N.C.
Jessica Serdinsky, Evergreen, Colo.
Stephen Fruhwirth, Portland, Ore.
Melissa Skinner, Springfield, Mo.
Emily Haager, Diamond Bar, Calif.
Chelsea A. Terrell, Slidell, La.
Kevin Hanson, Helena, Mont.
Molly A. Walters, Oshkosh, Wis.
Michelle K. Jones, Montara, Calif.
Max Winkler, Boulder, Colo.
Margaret Lapsanski, Lincroft, N.J.
Jennifer Wright, Burtonsville, Md.
"These students are outstanding role models for others who live with CF,” said Harold H. Shlevin, Ph.D., president and chief executive officer of Solvay Pharmaceuticals. "Their courage, resolve and pursuit of excellence are truly inspiring. We are honored to enhance their educational development with these scholarships."
Solvay Pharmaceuticals established the CREON® Family Scholarship program in 1993 as part of its efforts to provide education and support for patients and families affected by CF. Solvay Pharmaceuticals markets the pancreatic enzymes supplement CREON® MINIMICROSPHERES®. CF is a genetic disease affecting approximately 30,000 children and young adults in the United States. CF causes digestive and chronic lung problems that require frequent therapy.
Solvay Pharmaceuticals, Inc. (www.solvaypharmaceuticals-us.com) of Marietta, Georgia (USA), is a research-driven pharmaceutical company that seeks to fulfill unmet medical needs in the therapeutic areas of cardiology, gastroenterology, mental health, neuroscience, women's health and a select group of specialized markets including men’s health. It is a part of the global Solvay Pharmaceuticals organization whose core activities consist of discovering, developing and manufacturing medicines for human use. Solvay Pharmaceuticals is a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium.
